Table 2. Patient Characteristics.
Characteristic | BRT + TMZ (n = 257) | BRT alone (n = 242) | ||
---|---|---|---|---|
No. | % | No. | % | |
Sex | ||||
Male | 130 | 51 | 128 | 53 |
Female | 127 | 49 | 114 | 47 |
Median age, years | 59.8 | - | 59.2 | - |
Range | 37–79 | - | 29–81 | - |
KPS | ||||
≤ | 162 | 63 | 162 | 68 |
≥ | 51 | 20 | 40 | 16 |
Data not supplied | 44 | 17 | 40 | 16 |
Primary tumor site | ||||
Breast cancer | 79 | 31 | 73 | 30 |
NSCLC and others | 176 | 68 | 168 | 69 |
Unknown | 2 | 1 | 1 | 1 |
Extracranial metastases | ||||
Yes | 147 | 57 | 144 | 60 |
No | 88 | 34 | 85 | 35 |
Data not supplied | 22 | 9 | 13 | 5 |
RPA class | ||||
I | 35 | 14 | 31 | 13 |
II | 105 | 41 | 95 | 39 |
III | 20 | 8 | 18 | 8 |
Data not supplied | 97 | 37 | 98 | 40 |
No., number; BRT, brain radiation therapy; TMZ, temozolomide; KPS, Karnofsky performance status; NSCLC, non-small cell lung cancer; RPA, recursive partitioning analysis.